Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
PP&E Net
Fuji Pharma Co Ltd
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
PP&E Net
¥21.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
PP&E Net
¥2T
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
PP&E Net
¥421.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
PP&E Net
¥569.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
PP&E Net
¥426.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Astellas Pharma Inc
TSE:4503
|
PP&E Net
¥293.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
See Also
What is Fuji Pharma Co Ltd's PP&E Net?
PP&E Net
21.2B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's PP&E Net amounts to 21.2B JPY.
What is Fuji Pharma Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
7%
Over the last year, the PP&E Net growth was 13%. The average annual PP&E Net growth rates for Fuji Pharma Co Ltd have been 18% over the past three years , 13% over the past five years , and 7% over the past ten years .